New Treatment for Prostate Enlargement Enters Final Stage Clinical Trials
A new drug developed by Nymox Pharmaceutical may offer doctors a breakthrough in the treatment of a common affliction of men, an enlarged prostate or BPH (benign prostatic hyperplasia).